HIV1 GAG/POL DNA VACCINE GIVEN IM BY NEEDLE, SYRINGE AND BIOJECTOR 2000

HIV1 GAG/POL DNA 疫苗通过针头、注射器和 BIOJECTOR 2000 进行肌内注射

• 批准号: 6115670
• 负责人: BARNEY S GRAHAM
• 金额: $ 3.64万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6115670
• 关键词: AIDS vaccines; clinical research; clinical trial phase I; drug screening /evaluation; gag protein; human immunodeficiency virus 1; human subject; human therapy evaluation; hypodermic needle; placebos; vector vaccine

Perform a randomized, double blind, placebo controlled Phase I trial of the facilitated HIV-1 gag-pol DNA vaccine in forty lower risk , healthy , uninfected adult volunteers. We are still in recruitment and enrollment phase of this study.

进行一项随机、双盲、安慰剂对照的I期试验 易化HIV-1 Gag-PolDNA疫苗在40例低风险健康人群中的应用 ，未感染的成年志愿者。 我们仍处于本次研究的招募和招生阶段。